微小残留病灶在非小细胞肺癌中的研究进展与应用

被引：4

作者：

王珏

张乐乐

张鹏

机构：

[1] 同济大学医学院同济大学附属上海市肺科医院

来源：

生物医学转化 | 2021年 / 2卷 / 04期

关键词：

非小细胞肺癌; 微小残留病灶; 液体活检;

D O I：

暂无

中图分类号：

R734.2 [肺肿瘤];

学科分类号：

100117 [系统生物医学];

摘要：

部分非小细胞肺癌患者在早期治愈后会发生远期复发或转移,这可能与治疗后患者体内仍存在影像学或是实验室方法检测不到的肿瘤病灶,即微小残留病灶相关。这些肿瘤复发的潜在来源与患者较差的预后有着紧密的联系,因此,在非小细胞肺癌病程中对这些病灶的监测十分重要。目前,针对微小残留病灶的检测主要依靠于液体活检,包括了循环肿瘤DNA检测、循环肿瘤细胞检测等方法。通过无创的检测手段,残留的肿瘤病灶为我们提供了肿瘤的进展状况以及具体的分子信息,预测了患者的预后状况,并进一步指导后续治疗方案。在这篇综述中,我们将探讨微小残留病灶发生发展的机制与影响,并关注对其的监测在临床治疗过程中可能的应用前景。

引用

页码：49 / 59

页数：11

共 93 条

[1]

Better together: circulating tumor cell clustering in metastatic cancer [J].

Schuster, Emma ;

Taftaf, Rokana ;

Reduzzi, Carolina ;

Albert, Mary K. ;

Romero-Calvo, Isabel ;

Liu, Huiping .

TRENDS IN CANCER, 2021, 7 (11) :1020-1032

[2]

Drivers of dynamic intratumor heterogeneity and phenotypic plasticity [J].

Biswas, Antara ;

De, Subhajyoti .

AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2021, 320 (05) :C750-C760

[3]

Circulating Tumor DNA Analyses as a Potential Marker of Recurrence and Effectiveness of Adjuvant Chemotherapy for Resected Non-Small-Cell Lung Cancer.[J].Kuang Peng Peng;Li Ning;Liu Zui;Sun Tian Yu;Wang Shu Quan;Hu Jia;Ou Wei;Wang Si Yu.Frontiers in Oncology.2021,

[4]

Cancer Statistics, 2021 [J].

Siegel, Rebecca L. ;

Miller, Kimberly D. ;

Fuchs, Hannah E. ;

Jemal, Ahmedin .

CA-A CANCER JOURNAL FOR CLINICIANS, 2021, 71 (01) :7-33

[5]

Prognostic implications of preoperative versus postoperative circulating tumor DNA in surgically resected lung cancer patients: a pilot study [J].

Ohara, Shuta ;

Suda, Kenichi ;

Sakai, Kazuko ;

Nishino, Masaya ;

Chiba, Masato ;

Shimoji, Masaki ;

Takemoto, Toshiki ;

Fujino, Toshio ;

Koga, Takamasa ;

Hamada, Akira ;

Soh, Junichi ;

Nishio, Kazuto ;

Mitsudomi, Tetsuya .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (05) :1915-1923

[6]

Microsieves for the detection of circulating tumor cells in leukapheresis product in non-small cell lung cancer patients [J].

Tamminga, Menno ;

Oomens, Lisa ;

Hiltermann, T. Jeroen N. ;

Andree, Kiki C. ;

Tibbe, Arjan ;

Broekmaat, Joska ;

Schuuring, Ed ;

Terstappen, Leon W. M. M. ;

Groen, Harry J. M. .

TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (04) :1093-+

[7]

Targeting KRAS Mutant Non-Small-Cell Lung Cancer: Past, Present and Future [J].

Uras, Iris Z. ;

Moll, Herwig P. ;

Casanova, Emilio .

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (12) :1-30

[8]

Liquid Biopsies Using Circulating Tumor DNA in Non-Small Cell Lung Cancer [J].

Pellini, Bruna ;

Szymanski, Jeffrey ;

Chin, Re-, I ;

Jones, Paul A. ;

Chaudhuri, Aadel A. .

THORACIC SURGERY CLINICS, 2020, 30 (02) :165-+

[9]

Detection of PD-L1 Expression and Its Clinical Significance in Circulating Tumor Cells from Patients with Non-Small-Cell Lung Cancer [J].

Cheng, Yuxin ;

Wang, Ting ;

Lv, Xin ;

Li, Rutian ;

Yuan, Ling ;

Shen, Jie ;

Li, Yan ;

Yan, Tingting ;

Liu, Baorui ;

Wang, Lifeng .

CANCER MANAGEMENT AND RESEARCH, 2020, 12 :2069-2078

[10]

Tumor-Cell–Macrophage Fusion Cells as Liquid Biomarkers and Tumor Enhancers in Cancer.[J].Yariswamy Manjunath;David Porciani;Jonathan B. Mitchem;Kanve N. Suvilesh;Diego M. Avella;Eric T. Kimchi;Kevin F. Staveley-O’Carroll;Donald H. Burke;Guangfu Li;Jussuf T. Kaifi.International Journal of Molecular Sciences.2020, 5

← 1 2 3 4 5 6 7 8 9 10 →